|Podcasts|January 19, 2023

Let’s Get Social: The Ascendancy of Social Media to the Top of the Media Mix

Amanda Powers-Han, chief marketing officer at Greater Than One, talks with senior editor Fran Pollaro about the ascension of social media as an incremental investment to one that is foundational. The pair delve into the focus on HCPs, especially in the rare disease space, building out sophisticated targeting strategies via multiple data partners, and the different uses across the social landscape, especially with video—from HCP social sites like Dermo and Medscape to the topical Twitter and its recognized peers like TikTok, Facebook, LinkedIn, and YouTube.

About the speaker

Amanda Powers-Han is an established healthcare marketing and communications leader with over 20 years of experience and a proven track record of building brands, leading clients, and helping
propel Greater Than One into its position today. As CMO, Amanda is responsible for building strategic alliances, identifying new client opportunities, and leading marketing and media efforts.

About the PharmExec Podcast

The editors of Pharmaceutical Executive bring you the latest commercial insights to master the scienceof success. Podcast episodes examine current trends, key conferences, and critical topics in the
bio/pharmaceutical industry.

Listen to this podcast on SoundCloud, Spotify, Google Podcasts, or Apple Podcasts.


Related to this article

Pharmaceutical Executive Daily
FDA reportedly shelves its Commissioner’s National Priority Voucher program, Eli Lilly breaks ground on a $3.5 billion Pennsylvania manufacturing site for next-generation obesity treatments, and Parexel’s Stacy Hurt on how small protocol decisions can become enrollment and retention barriers.
Pharmaceutical Executive Daily
FDA approves Merck KGaA’s Pimjetmi for tenosynovial giant cell tumor, Parexel’s Stacy Hurt on when patient input should enter the clinical research process, and Ignite Proteomics’ Dr. Brian Corgiat on adjusting for tumor mutations in treatment decisions.